Cypress Capital Group Becton Dickinson & CO Transaction History
Cypress Capital Group
- $813 Million
- Q3 2025
A detailed history of Cypress Capital Group transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cypress Capital Group holds 3,098 shares of BDX stock, worth $591,656. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,098
Previous 3,098
-0.0%
Holding current value
$591,656
Previous $533,000
8.63%
% of portfolio
0.07%
Previous 0.07%
Shares
27 transactions
Others Institutions Holding BDX
# of Institutions
1,716Shares Held
257MCall Options Held
1.01MPut Options Held
544K-
Vanguard Group Inc Valley Forge, PA32.5MShares$6.2 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.25 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$3.1 Billion1.86% of portfolio
-
State Street Corp Boston, MA13.9MShares$2.65 Billion0.09% of portfolio
-
First Eagle Investment Management, LLC9.99MShares$1.91 Billion3.54% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $54.5B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...